0001213900-16-009897.txt : 20160104 0001213900-16-009897.hdr.sgml : 20160104 20160104173032 ACCESSION NUMBER: 0001213900-16-009897 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20151231 FILED AS OF DATE: 20160104 DATE AS OF CHANGE: 20160104 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: SOLIGENIX, INC. CENTRAL INDEX KEY: 0000812796 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 411505029 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 29 EMMONS DRIVE STREET 2: SUITE C-10 CITY: PRINCETON STATE: NJ ZIP: 08540 BUSINESS PHONE: 609-538-8200 MAIL ADDRESS: STREET 1: 29 EMMONS DRIVE STREET 2: SUITE C-10 CITY: PRINCETON STATE: NJ ZIP: 08540 FORMER COMPANY: FORMER CONFORMED NAME: DOR BIOPHARMA INC DATE OF NAME CHANGE: 20020329 FORMER COMPANY: FORMER CONFORMED NAME: ENDOREX CORP DATE OF NAME CHANGE: 19960916 FORMER COMPANY: FORMER CONFORMED NAME: IMMUNOTHERAPEUTICS INC DATE OF NAME CHANGE: 19920703 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Straube Richard CENTRAL INDEX KEY: 0001595197 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-16929 FILM NUMBER: 161319303 MAIL ADDRESS: STREET 1: 29 EMMONS DRIVE, SUITE C-10 CITY: PRINCETON STATE: NJ ZIP: 08540 4 1 f4123115straube_soligenix.xml OWNERSHIP DOCUMENT X0306 4 2015-12-31 0 0000812796 SOLIGENIX, INC. SNGX 0001595197 Straube Richard 29 EMMONS DRIVE, SUITE C-10 PRINCETON NJ 08540 0 1 0 0 Senior VP and CMO Stock Option (Right to Buy) 1.13 2015-12-31 4 A 0 70000 0 A 2015-12-31 2025-12-30 Common Stock 70000 70000 D The stock option vested immediately as to 17,500 shares and vests as to the remainder at a rate of 6.25% of the total shares underlying the stock option on each three (3) month anniversary of December 31, 2015. /s/ Richard Straube 2016-01-04